Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (35 quarters reported)
$174M in Q4 2017 → $1.93B now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| UT United Therapeutics Corp Del | 8.1% | Added 8.9% | 287,668 | $156M |
| Abivax Sa | 6.3% | Trimmed 2.2% | 913,880 | $122M |
| Encompass Health Corp | 5.4% | Added 429% | 1,026,919 | $104M |
| Ensign Group Inc | 5.0% | Added 3979% | 602,079 | $96.5M |
| Vera Therapeutics Inc | 4.9% | Added 1.8% | 2,212,770 | $94.9M |
| IQ Invesco Qqq Tr Put | 3.8% | Trimmed 59% | 98,600 | $72.6M |
| CT Celldex Therapeutics Inc New | 3.4% | Trimmed 0.1% | 1,785,941 | $66.5M |
| Syndax Pharmaceuticals Inc | 3.2% | Trimmed 3.0% | 2,798,210 | $61.2M |
| BS Brookdale Sr Living Inc | 2.8% | Trimmed 4.8% | 3,396,470 | $54.6M |
| Ionis Pharmaceuticals Inc | 2.7% | Added 5.2% | 664,684 | $52.7M |
| Natera Inc | 2.5% | Trimmed 54% | 175,807 | $47.7M |
| Travere Therapeutics Inc | 2.4% | Added 47% | 798,973 | $45.4M |
| Caretrust REIT Inc | 2.2% | New | 1,072,015 | $43.3M |
| Hca Healthcare Inc | 2.0% | Added 24% | 98,252 | $38.3M |
| Vaxcyte Inc | 1.9% | Trimmed 32% | 629,952 | $36.6M |
| Liquidia Corporation | 1.8% | Trimmed 37% | 428,652 | $34.2M |
| CH Community Health Sys Inc New | 1.4% | Trimmed 9.4% | 7,864,575 | $26.3M |
| Gsk PLC | 1.3% | Trimmed 73% | 481,833 | $25.3M |
| CN Chemed Corp New | 1.3% | Added 69% | 52,523 | $24.5M |
| EL Eli Lilly & Co | 1.3% | Added 5.9% | 20,116 | $24.1M |
| Geron Corp | 1.2% | Trimmed 0.6% | 18,717,422 | $24M |
| Viking Therapeutics Inc | 1.2% | Added 152% | 602,922 | $23.5M |
| OH Omega Healthcare Invs Inc | 1.2% | Trimmed 17% | 483,547 | $23.1M |
| Insulet Corp | 1.2% | Added 3.7% | 148,816 | $22.7M |
| Tenet Healthcare Corp | 1.1% | Added 287% | 114,199 | $21.4M |
| Unitedhealth Group Inc | 1.1% | New | 51,145 | $21.3M |
| Welltower Inc | 1.0% | Trimmed 52% | 87,312 | $19.8M |
| Beta Bionics Inc | 1.0% | Trimmed 12% | 1,249,441 | $19.6M |
| Cogent Biosciences Inc | 1.0% | New | 490,235 | $19M |
| Biocryst Pharmaceuticals Inc | 1.0% | Trimmed 39% | 1,865,653 | $18.7M |
| Molina Healthcare Inc | 1.0% | Added 146% | 80,594 | $18.4M |
| Pennant Group Inc | 0.9% | Added 47% | 460,272 | $17M |
| LP Ltc Pptys Inc | 0.8% | Added 31% | 420,640 | $16.2M |
| Insmed Inc | 0.8% | New | 149,209 | $15.9M |
| Viridian Therapeutics Inc | 0.8% | Added 17% | 831,142 | $15.3M |
| Biomarin Pharmaceutical Inc | 0.7% | Added 20% | 249,607 | $14.3M |
| AH Amn Healthcare Svcs Inc | 0.7% | New | 428,531 | $13.9M |
| Celcuity Inc | 0.7% | New | 127,931 | $13.4M |
| Pharvaris N V | 0.7% | Trimmed 5.1% | 386,383 | $13.4M |
| Cytomx Therapeutics Inc. | 0.7% | Added 12% | 3,558,497 | $13.3M |
| Humana Inc | 0.6% | New | 31,171 | $12.4M |
| Xenon Pharmaceuticals Inc | 0.6% | Added 52% | 196,532 | $11.9M |
| Corvus Pharmaceuticals Inc | 0.6% | New | 747,994 | $11.2M |
| Ascendis Pharma A/s | 0.6% | New | 41,621 | $11.1M |
| Bruker Corp | 0.6% | Added 56% | 182,894 | $11M |
| Moderna Inc | 0.6% | Trimmed 4.7% | 152,122 | $10.7M |
| Structure Therapeutics Inc | 0.5% | Added 42% | 196,302 | $10.5M |
| Insmed Inc Call | 0.5% | Added 2.8% | 96,600 | $10.3M |
| Definium Therapeutics Inc | 0.5% | Added 35% | 217,185 | $10.2M |
| Compass Pathways PLC | 0.5% | Trimmed 0.8% | 672,825 | $9.52M |
| NP Newamsterdam Pharma Company | 0.5% | Trimmed 3.6% | 275,471 | $9.34M |
| Revvity Inc | 0.5% | Trimmed 1.4% | 83,624 | $9.3M |
| Palisade Bio Inc | 0.5% | Trimmed 16% | 4,182,785 | $8.74M |
| Ardelyx Inc | 0.4% | Trimmed 25% | 1,678,345 | $8.56M |
| Mineralys Therapeutics Inc | 0.4% | New | 309,689 | $8.36M |
| Relay Therapeutics Inc | 0.4% | Added 60% | 434,314 | $8.13M |
| NA Novo-nordisk A S | 0.4% | New | 169,227 | $8.11M |
| Biohaven Ltd | 0.4% | New | 515,804 | $7.68M |
| Protagonist Therapeutics Inc | 0.4% | New | 58,504 | $7.17M |
| Enliven Therapeutics Inc | 0.4% | New | 136,631 | $6.93M |
Showing top 60 of 120 positions.
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed August 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IQ Invesco Qqq Tr | Trimmed | −140,100 | −$103M | 3.8% |
| Ensign Group Inc | Added | +587,318 | +$94.1M | 5.0% |
| Encompass Health Corp | Added | +832,815 | +$84.2M | 5.4% |
| SS State Str SPDR S&P 500 ETF T | Exited | −107,000 | −$69.6M | — |
| Gsk PLC | Trimmed | −1,303,342 | −$68.3M | 1.3% |
| Natera Inc | Trimmed | −208,906 | −$56.7M | 2.5% |
| Caretrust REIT Inc | New | +1,072,015 | +$43.3M | 2.2% |
| Vertex Pharmaceuticals Inc | Exited | −90,000 | −$40.2M | — |
| IT Ishares Tr | Exited | −428,800 | −$37.2M | — |
| Healthpeak Properties Inc | Exited | −1,981,070 | −$32.5M | — |
Showing the 10 largest of 145 changes.
quarter ended March 31, 2026 · filed May 15, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Gsk PLC | Trimmed | −894,546 | −$49.4M | 5.2% |
| BS Brookdale Sr Living Inc | Added | +3,193,626 | +$43.7M | 2.6% |
| Danaher Corporation | Exited | −186,262 | −$42.6M | — |
| SS State Str SPDR S&P 500 ETF T | Added | +62,100 | +$40.4M | 3.7% |
| Vertex Pharmaceuticals Inc | New | +90,000 | +$40.2M | 2.1% |
| Vera Therapeutics Inc | Trimmed | −899,018 | −$36.2M | 4.6% |
| Welltower Inc | New | +180,953 | +$35.8M | 1.9% |
| Healthpeak Properties Inc | New | +1,981,070 | +$32.5M | 1.7% |
| Abivax Sa | Added | +276,589 | +$30.8M | 5.5% |
| OH Omega Healthcare Invs Inc | New | +585,680 | +$25.7M | 1.4% |
Showing the 10 largest of 148 changes.
quarter ended December 31, 2025 · filed February 17, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Natera Inc | Trimmed | −185,151 | −$42.4M | 3.9% |
| Zimvie Inc | Exited | −2,079,380 | −$39.4M | — |
| Abivax Sa | Added | +231,335 | +$31.2M | 4.5% |
| SS SPDR S&P 500 ETF Tr | New | +44,900 | +$30.6M | 1.5% |
| Gsk PLC | Added | +559,275 | +$27.4M | 6.6% |
| Avantor Inc | Added | +2,252,202 | +$25.8M | 1.8% |
| Exact Sciences Corp | New | +241,678 | +$24.5M | 1.2% |
| Revvity Inc | Trimmed | −231,534 | −$22.4M | 0.8% |
| TP Teva Pharmaceutical Inds Ltd | Trimmed | −703,476 | −$22M | 1.0% |
| Cidara Therapeutics Inc | New | +98,721 | +$21.8M | 1.1% |
Showing the 10 largest of 122 changes.
quarter ended September 30, 2025 · filed November 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| UT United Therapeutics Corp Del | Added | +193,854 | +$81.3M | 7.3% |
| UN Uniqure Nv | New | +877,373 | +$51.2M | 3.5% |
| Natera Inc | Trimmed | −276,731 | −$44.5M | 5.8% |
| Abivax Sa | New | +426,499 | +$36.2M | 2.5% |
| IQ Invesco Qqq Tr | Added | +57,800 | +$34.7M | 9.5% |
| IM Inspire Med Sys Inc | Exited | −164,473 | −$21.3M | — |
| IH Iqvia Hldgs Inc | Exited | −97,604 | −$15.4M | — |
| Protagonist Therapeutics Inc | Exited | −277,316 | −$15.3M | — |
| Danaher Corporation | Added | +75,824 | +$15M | 1.4% |
| Insulet Corp | New | +45,604 | +$14.1M | 1.0% |
Showing the 10 largest of 94 changes.
quarter ended June 30, 2025 · filed August 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SS SPDR S&P 500 ETF Tr | Exited | −76,900 | −$43M | — |
| IQ Invesco Qqq Tr | Added | +48,600 | +$26.8M | 8.7% |
| Vaxcyte Inc | Added | +741,444 | +$24.1M | 3.9% |
| Healthequity Inc | Trimmed | −196,108 | −$20.5M | 1.5% |
| Revvity Inc | Added | +211,243 | +$20.4M | 4.5% |
| Hca Healthcare Inc | Trimmed | −52,519 | −$20.1M | 3.5% |
| Unitedhealth Group Inc | New | +60,736 | +$18.9M | 1.7% |
| Illumina Inc | New | +198,584 | +$18.9M | 1.7% |
| Avantor Inc | Added | +1,403,341 | +$18.9M | 1.9% |
| Neurocrine Biosciences Inc | Exited | −167,243 | −$18.5M | — |
Showing the 10 largest of 71 changes.
quarter ended March 31, 2025 · filed May 15, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IQ Invesco Qqq Tr | Trimmed | −119,500 | −$56M | 5.9% |
| Syndax Pharmaceuticals Inc | Added | +3,868,870 | +$47.5M | 5.3% |
| Gsk PLC | Trimmed | −1,038,522 | −$40.2M | 10.3% |
| SS SPDR S&P 500 ETF Tr | Added | +47,100 | +$26.3M | 4.4% |
| Neurocrine Biosciences Inc | New | +167,243 | +$18.5M | 1.9% |
| IM Inspire Med Sys Inc | Trimmed | −107,877 | −$17.2M | 3.0% |
| Vaxcyte Inc | Added | +429,482 | +$16.2M | 2.1% |
| Viatris Inc | Exited | −1,272,102 | −$15.8M | — |
| IT Ishares Tr | Exited | −179,400 | −$15.7M | — |
| Glaukos Corp | New | +158,957 | +$15.6M | 1.6% |
Showing the 10 largest of 76 changes.
quarter ended December 31, 2024 · filed February 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Insmed Inc | Exited | −1,089,404 | −$79.5M | — |
| Syndax Pharmaceuticals Inc | Trimmed | −3,761,913 | −$49.7M | 0.4% |
| UT United Therapeutics Corp Del | Trimmed | −87,246 | −$30.8M | 1.4% |
| Bio-techne Corp | Trimmed | −364,263 | −$26.2M | 1.9% |
| TP Teva Pharmaceutical Inds Ltd | Trimmed | −992,513 | −$21.9M | 4.4% |
| Vera Therapeutics Inc | Trimmed | −450,142 | −$19M | 6.0% |
| CH Community Health Sys Inc New | Trimmed | −5,949,455 | −$17.8M | 0.8% |
| SS SPDR S&P 500 ETF Tr | Trimmed | −30,200 | −$17.7M | 1.6% |
| Repligen Corp | Trimmed | −109,527 | −$15.8M | 0.7% |
| IT Ishares Tr | New | +179,400 | +$15.7M | 1.4% |
Showing the 10 largest of 77 changes.
quarter ended September 30, 2024 · filed November 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IM Inspire Med Sys Inc | Trimmed | −256,741 | −$54.2M | 4.0% |
| Natera Inc | Trimmed | −303,301 | −$38.5M | 7.6% |
| UT United Therapeutics Corp Del | Trimmed | −104,402 | −$37.4M | 3.2% |
| TP Teva Pharmaceutical Inds Ltd | Trimmed | −1,485,822 | −$26.8M | 4.0% |
| Gsk PLC | Added | +589,126 | +$24.1M | 11.4% |
| NA Novo-nordisk A S | Exited | −146,956 | −$21M | — |
| Zimvie Inc | Added | +1,303,121 | +$20.7M | 2.3% |
| EL Eli Lilly & Co | Exited | −21,233 | −$19.2M | — |
| IQ Invesco Qqq Tr | Trimmed | −36,000 | −$17.6M | 8.3% |
| SS SPDR S&P 500 ETF Tr | Added | +29,200 | +$16.8M | 2.4% |
Showing the 10 largest of 82 changes.
Loading...
